Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development

Galapagos and Gilead expand collaboration to advance T cell engager programme

Aurinia Pharmaceuticals agrees to acquire Kezar Life Sciences

Thermo Fisher Scientific and SHL Medical launch integrated US drug-device manufacturing

Immunic granted European patent for vidofludimus calcium dosing regimens

Sanofi's rilzabrutinib receives orphan drug designation in Japan for IgG4-related disease

Johnson & Johnson submits sBLA to FDA for first-ever treatment for wAIHA

Genentech reports positive Phase III MAJESTYdata for Gazyva in primary membranous nephropathy

STADA and Bio-Thera Solutions receive European marketing authorisation for Gotenfia (golimumab)

Amgen wins European approval for Uplizna in generalised myasthenia gravis

Akeso's AK139 Phase II clinical trials approved in China

Eli Lilly signs definitive agreement to acquire Orna Therapeutics

Sanofi's rilzabrutinib receives FDA breakthrough and Japan orphan designations for rare anaemia

AbbVie submits FDA and EMA applications for new upadacitinib indication in NSV

WuXi Biologics enters into licence and research service agreement with Vertex Pharmaceuticals